In fields such as gene therapy, nucleic acid vaccines, and functional genomics, efficient in vivo delivery technologies are critical for advancing scientific research and clinical translation. To provide comprehensive and reliable delivery tools for research and drug development, Protheragen has launched In Vivo LNP Delivery Kits tailored to diverse in vivo application needs.

Product Features

1. Comprehensive delivery solutions spanning broad-spectrum delivery to organ/cell-specific delivery

Traditional nucleic acid delivery technologies are often limited by low delivery efficiency and poor targeting，and our In Vivo LNP Delivery Kits offer a turnkey solution.

• General-purpose delivery: Compatible with multiple injection methods and different nucleic acid types, meeting the needs of basic research and drug screening.
• Organ-targeted delivery: Efficiently targets important organs such as the liver, spleen, lungs, and skin, supporting organ-specific therapeutic research.

2. Targeted delivery of immune cells

Immune cells are key targets in immunotherapy, vaccine development and autoimmune disease research, but traditional delivery methods are often inefficient or unsafe. In Vivo LNP Delivery Kits are formulated to efficiently deliver nucleic acids to immune cells such as macrophages, dendritic cells and T cells.

Core Advantages

• High delivery efficiency
• Precise targeting
• Low toxicity
• High biocompatibility
• Ready-to-use

Protheragen's finely tuned In Vivo LNP Delivery Kits product formulation is dedicated to supporting global nucleic acid drug research. If you need more product details, please contact us.